Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Outcomes4Me has developed a widely adopted AI-powered digital health platform that integrates clinical guidelines (including NCCN Guidelines®), genomics data, trial matching, and symptom tracking to provide personalized treatment guidance to over 280,000 cancer patients globally. The company has demonstrated rapid revenue growth since its commercial launch in 2022 and collaborates with seven of the top ten global oncology pharmaceutical companies. Its app has been independently recognized as the highest quality application among more than 3,000 evaluated for adult cancer patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Outcomes4Me.